Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Shengfen Wang

Value of Pyrazinamide for Composition of New Treatment Regimens for Multidrug-Resistant Mycobacterium Tuberculosis in China

BMC Infectious Diseases

Infectious Diseases

English

Related publications

Revolutionary New Treatment Regimens for Multidrug-Resistant Tuberculosis

The Lancet Infectious Diseases

Infectious Diseases

English

Pyrazinamide May Improve Fluoroquinolone-Based Treatment of Multidrug-Resistant Tuberculosis

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Bedaquiline: New Approach for Treatment of Multidrug-Resistant Tuberculosis

RUHS Journal of Health Science

English

Treatment Outcomes of Rifabutin-Containing Regimens for Rifabutin-Sensitive Multidrug-Resistant Pulmonary Tuberculosis

International Journal of Infectious Diseases

Infectious Diseases

English

Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis

Clinical Microbiology and Infection

Infectious Diseases

English

Reply to Anthony Et Al., “Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment”

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Multidrug-Resistant Mycobacterium Tuberculosis: Molecular Perspectives

Emerging Infectious Diseases

Infectious Diseases

English

Characterization of pncA Mutations in Pyrazinamide-Resistant Mycobacterium Tuberculosis in Brazil

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Shorter Regimens for Multidrug-Resistant Tuberculosis Should Also Be Applicable in Europe

European Respiratory Journal

Respiratory Medicine

English